In this GEN webinar, our guest presenter Daisy Hoagland from Icahn School of Medicine, will tell us how she and her colleagues used a broad range of small animal models to understand the host response to SARS-CoV-2. Moreover, the presentation will focus on the strengths of the golden hamster model in studying transmission, intrahost viral dissemination, pathology, and its utility in screening for effective antivirals.
In this GEN webinar, sponsored by Sino Biological, our distinguished speaker Dr. Jacob Glanville, CEO and president of Centivax, will present data on computational immunology interrogation of the adaptive immune response to better understand why immune responses rarely target conserved epitopes. R&D Manager of Sino Biological, Dr. Yuning Chen, will also share with us the viral antigen bank they’ve developed. Finally, our presenters will discuss ongoing efforts in new pathogen arenas, including the novel coronavirus and HIV.
The synthetic biology revolution is here! In this presentation, sponsored by Twist Bioscience, we are excited to bring together leaders in the field. Our April episode of GEN Live, our guests discuss where the field is now and the exciting advances in store for the future.
In this GEN webinar, sponsored by OXGENE, our panelists—two industry leaders—will discuss what it takes to develop a cell or gene therapy from concept to commercialization, alongside a conversation about innovations that are likely to shape the future of advanced therapy discovery and biomanufacturing.
In this GEN webinar, sponsored by 10X Genomics, Dr. Florian Wimmers from Stanford University takes us to the beginning of the COVID-19 pandemic, recounting how he and his colleagues leveraged and integrated a range of techniques, including Multiomic Cytometry (also known as CITE-seq), CyTOF, Olink, and blood transcriptional profiling, to uncover fundamental immune signatures of severe and moderate COVID-19.
In this GEN webinar, sponsored by Horizon Discovery, we will present data showing how a new CRISPRsc screening platform from Horizon offers a streamlined approach to elucidating valuable and intriguing biological information critical to resolving complex biological questions.
REGISTER NOW Broadcast Date: February 5, 2019Time: 8:00 am PT, 11:00 am ET, 17:00 CET Antibody-drug conjugates select ADCs) were initially developed to provide a selective targeting mechanism...
GEN's on demand webinar, sponsored by Dassault Systèmes, discusses the current state of The Living Brain Project and how it is being applied to traumatic brain injury, neuromodulation, neurodegenerative disease progression, and drug delivery through cerebrospinal fluid.
This presentation will show how low concentrated samples, as well as libraries prepared for long read sequencing benefit from QC, performed with the Femto Pulse.
While the importance of ligand-receptor binding kinetics on drug action is becoming well established, focus to date has been almost entirely on the role of the dissociation constant on drug efficacy and duration of action. The association rate constant, in contrast, has been largely overlooked, with many investigators still considering it diffusion-limited and equivalent across a compound series. This GEN webinar aims to remedy that by turning the spotlight onto the undervalued and oft-ignored association rate constant.
In this GEN webinar, we will hear from Danica Stanimirovic MD, PhD, and Danica Stanimirovic MD, PhD, wto leading scientists who will describe their current antibody engineering research projects and the therapeutic potential they hold.
In this GEN webinar sponsored by Advanced Cell Diagnostics, we will hear about new PDAC research showing that the cytokine leukemia inhibitory factor (LIF) key paracrine factor from activated pancreatic stellate cells acting on cancer cells.
In this GEN webinar, we will learn from Dr. Daniel Lauster, who, when faced with many of the challenges described above, utilized MicroScale Thermophoresis (MST) to measure the interaction between more than 100 novel non-toxic multivalent nanoparticle-conjugates and intact IAV in solution with as little as nanomoles of nanoparticles. Additionally, we will hear from Dr. Matthias Molnar how MST is becoming scientists’ first choice for the characterization of molecular interactions thanks to its flexible throughput, low sample consumption, and measurements in solution or in close to native conditions.
In this GEN webinar, we will hear about recent findings implicating the Hippo effector, Yap, as a driver of a novel damaged-induced intestinal stem cell population.
In this roundtable, our panelists will discuss assessing the validity of biomarkers to inform drug development and potential combination therapies. Key considerations include predictive testing of biomarkers, analytical methods, drug-diagnostic co-development and potential reimbursement considerations.
In this webinar, we will learn from Dr. Marcel Tigges about some of the production challenges faced by researchers working on large molecule process development. Additionally, we will hear from Dr. Silvia Würtenberger, on how Prometheus is the new gold standard that precisely characterizes protein stability by looking at thermal and chemical unfolding of proteins in a label-free way, using a tiny amount of sample.